Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
EPA Asks Court To Retract Approval Of Glyphosate-Based Enlist Duo Weed Killer December 2, 2015 Irvin Jackson Add Your CommentsEnvironmental regulators have asked a panel of federal judges to revoke approval for the recently introduced herbicide Enlist Duo, which uses the controversial chemical glyphosate that is also found in Roundup, and has recently been linked to a potential risk of cancer for humans.ย In a brief (PDF) filed on November 24, the U.S. Environmental Protection Agency (EPA) asked the U.S. Court of Appeals for the Ninth Circuit to revoke it’s approval of the Dow Chemical pesticide, saying that it has learned that glyphosate and 2,4-D, another ingredient used in the chemical, can amplify each other’s effects.The EPA warns that the combination could make Enlist Duo more toxic than it anticipated.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe request came as part of an ongoing lawsuit against the EPA brought by the Natural Resources Defense Council, a powerful environmental advocacy group, which is one of the leading critics indicating that the EPA’s decision to approve Enlist Duo in 2014 was based on flawed science.Glyphosate, the active ingredient most known for its use in Monsanto’s weed killer Roundup, was deemed to be a probably carcinogen in March by the International Agency for Research on Cancer (IARC), an arm of the World Health Organization. The designation has led some countries to ban Roundup and other glyphosate-based pesticides.The chemical 2,4-D was used in Agent Orange, a defoliant during the Vietnam War, which has been linked to a number of illnesses afflicting veterans of the war.According to the EPA’s brief, when it first reviewed the available data on Enlist Duo, it determined that there were no indications of synergism between the two chemicals that affected mammals or fish.“Recently, however, EPA discovered that Dow made claims of ‘synergistic herbicidal weed control’ in its Provisional and Non-provisional patent applications for Enlist Duo. The Provisional application was filed on December 20, 2013, and the final application was filed on December 11, 2014,” the brief states. “Accordingly, in light of the new information regarding the potential synergism of the two Enlist Duo ingredients, EPA seeks a voluntary remand with vacatur to reconsider the Enlist Duo registration.”The EPA indicates that it contacted Dow after discovering the synergism claims, and warned the company that this would assess how the regulators factored the potential impacts to non-target organisms. Dow responded with more data, which the EPA is still reviewing. However, the preliminary findings led EPA reviewers to conclude that a 30-foot buffer it required around application areas for Enlist Duo may be insufficient.Glyphosate Cancer Side EffectsThe decision comes amid mounting concerns about the human health side effects of glyphosate, and questions about whether exposure to Roundup may increase the risk of non-Hodgkin lymphoma or other cancers.Roundup is one of the most widely used herbicides, which was introduced by Monsanto in the 1970s. There are now a number of Roundup lawsuits being pursued against Monsanto by former farmers and other individuals exposed to large amounts of the weedkiller, whichย allege that the manufacturer failed to adequately warn consumers and the agricultural industry that glyphosate may be a human carcinogen.Monsanto has attempted to dismiss the concerns that Roundup is a human carcinogen, maintaining that the IARCโs conclusions were agenda-driven and based on โjunk science.โ The manufacturer has said it is convening its own independent panel to review the cancer risks of Roundup.Consumer use of Roundup began to skyrocket in the mid 1990s, after Monsanto introduced genetically engineered crops to withstand treatment with Roundup, killing the weeds and not the crops. Genetically modified crops, like corn and soybean, are branded as being โRoundup Ready.โ Some weeds have developed resistance to glyphosate, thus forcing farmers to use higher quantities of Roundup.The U.S. Geological Survey estimated agricultural use of glyphosate increased drastically from 110 million pounds in 2002, now to more than 283 million pounds in 2012.The U.S. Environmental Protection Agency (EPA) announced in April that it plans to address the safety concerns of glyphosate during the regular EPA safety review hearing occurring soon. Researchers warn pesticides are commonly detected in the air, food and water near areas that have been sprayed. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Chemicals, Dow, Enlist Duo, Glyphosate, Herbicide, RoundupMore Roundup Lawsuit Stories Roundup Cancer Lawsuit Trial Underway in Missouri Court October 5, 2026 U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings June 25, 2026 Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (Posted: today)A woman’s lawsuit accuses Novo Nordisk of ignoring and downplaying risks of vision loss linked to GLP-1 drugs like Ozempic.MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss (09/15/2026) $46.5M Silicosis Lawsuit Payout Awarded Against Quartz Countertop Manufacturer (Posted: yesterday)A silicosis lawsuit trial has ended in a California jury ordering a quartz countertop manufacturer to pay a dying man $46.5 million.MORE ABOUT: SILICOSIS LAWSUITInsurer Denies Coverage for Silica Lawsuit Against Stone Manufacturer (10/12/2026)Silicosis Lung Injuries Drive California Push to Ban Artificial Stone Countertops (09/28/2026)Silicosis Risk From Engineered Stone Countertops May Persist Despite Safety Measures: Study (09/25/2026) Five Hair Relaxer Lawsuits Over Cancer Risks Selected for Bellwether Trials (Posted: 2 days ago)A federal judge has announced the selection of five hair relaxer lawsuits to serve as a series of bellwether trials over claims that the chemical straighteners caused women to develop reproductive cancers.MORE ABOUT: HAIR RELAXER LAWSUITFirst Hair Relaxer Cancer Lawsuit Set for Bellwether Trial on Sept. 7, 2027 (09/28/2026)L’Oreal Faces State AG Lawsuit Over Cancer Risks From Hair Relaxers (09/15/2026)L’Oreal Execs To Face More Questions Over Dark and Lovely, Hair Relaxer Cancer Risks (06/29/2026)
Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (Posted: today)A woman’s lawsuit accuses Novo Nordisk of ignoring and downplaying risks of vision loss linked to GLP-1 drugs like Ozempic.MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss (09/15/2026)
$46.5M Silicosis Lawsuit Payout Awarded Against Quartz Countertop Manufacturer (Posted: yesterday)A silicosis lawsuit trial has ended in a California jury ordering a quartz countertop manufacturer to pay a dying man $46.5 million.MORE ABOUT: SILICOSIS LAWSUITInsurer Denies Coverage for Silica Lawsuit Against Stone Manufacturer (10/12/2026)Silicosis Lung Injuries Drive California Push to Ban Artificial Stone Countertops (09/28/2026)Silicosis Risk From Engineered Stone Countertops May Persist Despite Safety Measures: Study (09/25/2026)
Five Hair Relaxer Lawsuits Over Cancer Risks Selected for Bellwether Trials (Posted: 2 days ago)A federal judge has announced the selection of five hair relaxer lawsuits to serve as a series of bellwether trials over claims that the chemical straighteners caused women to develop reproductive cancers.MORE ABOUT: HAIR RELAXER LAWSUITFirst Hair Relaxer Cancer Lawsuit Set for Bellwether Trial on Sept. 7, 2027 (09/28/2026)L’Oreal Faces State AG Lawsuit Over Cancer Risks From Hair Relaxers (09/15/2026)L’Oreal Execs To Face More Questions Over Dark and Lovely, Hair Relaxer Cancer Risks (06/29/2026)